In conclusion, our data indicate that the HDL cholesterol efflux capacity and therefore its antitumor activity is regulated by the HDL particle composition and/or the expression pattern of cell surface receptors such as SR-B1 and ABCA1 on tumor cells. This evidence concerns the gene ABCA1 and neoplasm.